Jump to content

IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors outside of Uveal Melanoma and a Collaboration with Foundation Medicine in support of its Tumor-Agnostic GNAQ/11 Basket Trial

In The News

Recommended Posts


This topic is now archived and is closed to further replies.

  • Create New...